General Information
| Application | Inhibitor |
|---|
| Description | Ertugliflozin, a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2, is currently in phase 2 trials for the treatment of diabetes mellitus. |
|---|---|
| Cas NO. | 1210344-57-2 |
| Purity | 98 % |
|---|---|
| Molecular Weight |
436.88 |
| Formula | C22H25ClO7 |
| Target / IC50 |
hSGLT2 : 0.877 nM |
|---|---|
| Solubility |
DMSO : 87 mg/ml Water : 87 mg/ml Ethanol : 87 mg/ml |
| Storage | -20℃ |
| Alias | MK-8835, PF-04971729 |
|---|
.png)